Bacterial Sialadenitis Market, By Type, By Type of Bacteria, By Gland Type, By Drug Class, By Distribution Channel, By Geography

Description

The global bacterial sialadenitis market size is projected to reach US$ 664.4 million by 2030, from US$ 467.8 million in 2023, growing at a CAGR of 5.1% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 467.8 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.10%	2030 Value Projection:	US$ 664.4 Mn

Figure 1. Global Bacterial sialadenitis Market Share (%), by Region, 2023

Sialadenitis is swelling and enlargement of the major salivary glands, the parotid (in front of each ear), submandibular (under the tongue on the floor of the mouth) or sublingual (below the tongue in the back of the mouth). It can be acute (sudden) or chronic (long-term) or recurrent. The condition can be caused by infection or by a blockage of the gland's ducts. A common cause of bacterial sialadenitis is Staphylococcus aureus, but other organisms may also be responsible. Bacterial sialadenitis is usually painful and may be accompanied by fever and chills. The affected gland is swollen, red and tender and usually has a central area of discoloration, which may indicate an abscess.

Preventive measures include maintaining good oral hygiene, drinking enough water, and addressing underlying conditions that increase the risk of bacterial sialadenitis. Regular dental care and avoiding risk factors can help reduce the likelihood of developing the condition. The primary treatment for bacterial sialadenitis is antibiotic therapy to target the specific bacteria causing the infection. Adequate hydration, warm compresses, and gland massage may also be recommended to promote saliva flow and relieve symptoms. In some cases, surgical intervention may be necessary to remove salivary stones or drain abscesses.

Market Dynamics:

The global bacterial sialadenitis market is expected to witness significant growth in the coming years owing to rising incidence of conditions such as salivary gland infections, sialadenitis, and autoimmune diseases such as Sjogren's syndrome.

High cost of treatment and complications associated with the infection are expected to hinder growth of the global bacterial sialadenitis market over the forecast.

Key features of the study:

This report provides an in-depth analysis of the global bacterial sialadenitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bacterial sialadenitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market

Detailed Segmentation:

By Type:
- Acute
- Chronic
Type of Bacteria:
- Staphylococcus aureus
- Streptococcus viridans
- Pseudomonas aeruginosa
- Escherichia coli
- Others (Haemophilus influenza, etc.)
By Gland Type:
- Parotid
- Submandibular
- Sublingual
By Drug Class
- Antibiotics
- Dicloxacillin
- Cephalosporin
- Clindamycin
- Analgesics
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Ecommerce
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Company Profiles:
- Pfizer Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi S.A.
- Johnson & Johnson
- Abbott Laboratories
- Eli Lilly and Company
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Roche Holding AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Allergan plc.

Product Code: CMI5810

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bacterial Sialadenitis Market, By Type
- Market Bacterial Sialadenitis Market, By Type of Bacteria
- Market Bacterial Sialadenitis Market, By Gland Type
- Market Bacterial Sialadenitis Market, By Drug Class
- Market Bacterial Sialadenitis Market, By Distribution Channel
- Market Bacterial Sialadenitis Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bacterial Sialadenitis Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bacterial Sialadenitis Market, By Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Bacterial Sialadenitis Market, By Type of Bacteria, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Streptococcus viridans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Bacterial Sialadenitis Market, By Gland Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Paratoid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Submandibular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Bacterial Sialadenitis Market, By Drug Class, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Dicloxacillin
Cephalosporin
Clindamycin
- Analgesic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Bacterial Sialadenitis Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Ecommerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Bacterial Sialadenitis Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
North Africa
South Africa
Central Africa

11. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi S.A.
Johnson & Johnson
Abbott Laboratories
Eli Lilly and Company
AstraZeneca plc.
Bayer AG
Analyst Views

12. Section

Research Methodology
About us